search
radiation oncology
Trends
- 1Penn Medicine and IBA Launch Proton Therapy Joint Venture▼Penn Medicine, IBA Form Joint Venture to Advance Proton Therapy, Radiation Oncology
Penn Medicine and Belgian proton therapy company IBA have formed a joint venture aimed at advancing proton therapy and radiation oncology. The partnership will focus on developing and expanding access to advanced cancer radiation treatments. Details on investment size, timeline and specific projects have not been announced, and the companies have not yet outlined how the venture will operate alongside existing clinical programs.
- 2Mount Sinai to test novel liquid radioembolic agent for brain tumors●Mount Sinai announces collaborative research agreement to evaluate novel liquid radioembolic agent for brain tumors
Mount Sinai has announced a collaborative research agreement to evaluate a novel liquid radioembolic agent for treating brain tumors. The therapy would deliver radiation directly to tumor tissue in liquid form, an approach being explored for cancers that are difficult to treat surgically. Details on the partner institution, trial design and timeline have not yet been released, and clinical results remain pending.
- 3Penn Medicine and IBA Launch Global Proton Therapy Venture▼Penn Medicine and IBA Launch Joint Venture to Advance Proton Therapy and Radiation Oncology Program Development Worldwide
Penn Medicine and Belgian proton therapy company IBA have announced a joint venture to support the development of proton therapy and radiation oncology programs worldwide. The partnership aims to help hospitals and clinics internationally establish and expand advanced cancer treatment services, combining Penn Medicine's clinical expertise with IBA's technology. The announcement has been picked up by financial and international news outlets.